First clinical results obtained with cycloserine in the treatment of human tuberculosis.
作者信息
ALBOUY R, ELOY P, PESTEL M, RAVINA A, REY M
出版信息
Antibiot Annu. 1955;3:148-52.
PMID:13355259
Abstract
摘要
相似文献
1
First clinical results obtained with cycloserine in the treatment of human tuberculosis.环丝氨酸治疗人类结核病的首批临床结果
Antibiot Annu. 1955;3:148-52.
2
The treatment of human tuberculosis with cycloserine: a year's progress.用环丝氨酸治疗人类结核病：一年来的进展。
Antibiot Annu. 1955;3:141-7.
3
[A new antibiotic and tuberculosis medication; cycloserine; paradoxical comparisons clinical and experimental results].
Presse Med (1893). 1955 Nov 26;63(79):1637-9.
4
[Treatment of human tuberculosis by cycloserine].
Presse Med (1893). 1956 Jul 4;64(53):1241-5.
5
[Cycloserine, a new antibiotic, effective against tuberculosis].
Nord Med. 1956 Oct 18;56(42):1517-21.
6
Cycloserine-isoniazid in the ambulatory treatment of active tuberculosis after failure of previous chemotherapy.对既往化疗失败的活动性结核病进行门诊治疗时使用环丝氨酸-异烟肼。
Am Rev Respir Dis. 1959 Jul;80(1, Part 1):89-94. doi: 10.1164/arrd.1959.80.1P1.89.
7
[Preliminary study on the use of cycloserine in the treatment of pulmonary tuberculosis].
Rev Mex Tuberc Enferm Apar Respir. 1957 Sep-Oct;18(5):429-36.
8
Cycloserine: beneficial effects on experimental tuberculosis in guinea pigs.环丝氨酸：对豚鼠实验性结核病的有益作用。
Proc Staff Meet Mayo Clin. 1956 Oct 3;31(20):531-7.
9
The convulsive effect of cycloserine.环丝氨酸的惊厥作用。
Antibiotic Med Clin Ther (New York). 1956 Sep;3(4):258-62.
10
[Preliminary observations in the treatment of pulmonary tuberculosis with D-4-amino-3-isosazolidone (cycloserine)].
G Ital Della Tuberc. 1956 Mar-Apr;10(2):71-81.
引用本文的文献
1
Structural determinants of D-cycloserine efficacy at the NR1/NR2C NMDA receptors.D-环丝氨酸在 NR1/NR2C NMDA 受体上的疗效的结构决定因素。
J Neurosci. 2010 Feb 17;30(7):2741-54. doi: 10.1523/JNEUROSCI.5390-09.2010.
Zotero 插件